Matinas BioPharma
MTNB
#10268
Rank
โ‚น0.28 B
Marketcap
โ‚น55.47
Share price
9.97%
Change (1 day)
-94.40%
Change (1 year)

Earnings for Matinas BioPharma (MTNB)

Earnings in 2024 (TTM): -โ‚น1.77 Billion

According to Matinas BioPharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โ‚น1.99 Billion a decrease over its 2022 earnings that were of -โ‚น1.82 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Matinas BioPharma from 2013 to 2024

201620192022- โ‚น2B- โ‚น1.5B- โ‚น1B- โ‚น0.5Bโ‚น0.5B0companiesmarketcap.com

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚น1.77 Billion-11.35%
2023 -โ‚น1.99 Billion9.26%
2022 -โ‚น1.82 Billion-9.82%
2021 -โ‚น2.02 Billion3.73%
2020 -โ‚น1.95 Billion29.21%
2019 -โ‚น1.51 Billion19.07%
2018 -โ‚น1.27 Billion-7.91%
2017 -โ‚น1.38 Billion108.5%
2016 -โ‚น0.66 Billion-16.82%
2015 -โ‚น0.8 Billion-10.62%
2014 -โ‚น0.89 Billion175.27%
2013 -โ‚น0.33 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น11.68 Billion 537.67%๐Ÿ‡บ๐Ÿ‡ธ USA